Top 10 Expectorant & Mucus Relief Product Brands in China

Robert Gultig

10 December 2025

Top 10 Expectorant & Mucus Relief Product Brands in China

User avatar placeholder
Written by Robert Gultig

10 December 2025

Introduction:

The demand for expectorant and mucus relief products in China has been steadily increasing due to factors such as air pollution, smoking habits, and respiratory illnesses. As one of the largest markets for healthcare products in the world, China has seen a rise in the consumption of expectorants and mucus relief products. According to a recent market research report, the expectorant market in China is expected to reach a value of $X million by 2025.

Top 10 Expectorant & Mucus Relief Product Brands in China:

1. Yunnan Baiyao Group Co., Ltd.
Yunnan Baiyao Group Co., Ltd. is a leading Chinese pharmaceutical company known for its expectorant and mucus relief products. With an annual production volume of over X million units, the company holds a significant market share in China.

2. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. is another key player in the Chinese market for expectorant and mucus relief products. The company’s products are highly regarded for their effectiveness and quality, contributing to its strong presence in the market.

3. Tasly Pharmaceutical Group Co., Ltd.
Tasly Pharmaceutical Group Co., Ltd. is a renowned Chinese pharmaceutical company that offers a range of expectorant and mucus relief products. With a focus on innovation and research, the company continues to expand its market share in China.

4. Sinopharm Group Co., Ltd.
Sinopharm Group Co., Ltd. is a leading healthcare company in China that produces expectorant and mucus relief products. The company’s extensive distribution network and strong brand reputation have helped it maintain a competitive edge in the market.

5. China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited is a major player in the Chinese pharmaceutical industry, offering a variety of expectorant and mucus relief products. The company’s commitment to quality and customer satisfaction has earned it a loyal consumer base in China.

6. Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a well-established pharmaceutical company in China that specializes in expectorant and mucus relief products. The company’s extensive product portfolio and strong marketing strategies have contributed to its success in the market.

7. Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd. is a leading pharmaceutical company in China that manufactures expectorant and mucus relief products. With a focus on research and development, the company continues to introduce innovative products to meet the needs of consumers in China.

8. Nanjing Pharmaceutical Co., Ltd.
Nanjing Pharmaceutical Co., Ltd. is a key player in the Chinese market for expectorant and mucus relief products. The company’s commitment to quality control and product safety has earned it a reputation as a trusted brand among consumers in China.

9. Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is a prominent pharmaceutical company in China known for its expectorant and mucus relief products. The company’s strong sales performance and growing market share reflect its success in meeting the healthcare needs of consumers in China.

10. Jiangxi Yuyue Medical Equipment & Supply Co., Ltd.
Jiangxi Yuyue Medical Equipment & Supply Co., Ltd. is a leading manufacturer of expectorant and mucus relief products in China. The company’s focus on product innovation and quality has helped it establish a strong presence in the market.

Insights:

The expectorant and mucus relief product market in China is expected to continue growing in the coming years, driven by factors such as increasing air pollution levels and a rising prevalence of respiratory diseases. With a growing emphasis on healthcare and wellness, Chinese consumers are increasingly turning to expectorant and mucus relief products to manage their respiratory symptoms. As the market expands, pharmaceutical companies in China will need to focus on product innovation, quality control, and marketing strategies to stay competitive and meet the evolving needs of consumers. According to industry experts, the expectorant market in China is projected to grow at a CAGR of X% from 2021 to 2026, reaching a market value of $X million by the end of the forecast period.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →